Chemokine-binding protein and methods of use

Details Chemokine-binding protein and methods of use Chemokine-binding protein and methods of use

2003-06-19

2010-12-28

Helms, Larry R. (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S007100, C435S069500

Reexamination Certificate

active

07858297

ABSTRACT:
Described herein are chemokine-binding domains of THAP-family polypeptides and pharmaceutical compositions which include a polypeptide comprising a chemokine-binding domain of a THAP-family polypeptide. Also disclosed are methods of binding chemokines, inhibiting the activity of chemokines, detecting chemokines, and reducing the symptoms associated with a chemokine mediated or influenced condition by contacting the chemokine with an agent that includes a polypeptide comprising a chemokine binding domain of a THAP-family polypeptide.

REFERENCES:
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4656127 (1987-04-01), Mundy
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4736866 (1988-04-01), Leder et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5116947 (1992-05-01), Pinori et al.
patent: 5116964 (1992-05-01), Capon et al.
patent: 5143854 (1992-09-01), Pirrung et al.
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5219089 (1993-06-01), Kiolbasa et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5225539 (1993-07-01), Winter
patent: 5270181 (1993-12-01), McCoy et al.
patent: 5283317 (1994-02-01), Saifer et al.
patent: 5292646 (1994-03-01), McCoy et al.
patent: 5424186 (1995-06-01), Fodor et al.
patent: 5428130 (1995-06-01), Capon et al.
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5457035 (1995-10-01), Baum et al.
patent: 5783667 (1998-07-01), Wang
patent: 5834419 (1998-11-01), McFadden et al.
patent: 5871740 (1999-02-01), Smith
patent: 5897999 (1999-04-01), Vogelstein et al.
patent: 6191269 (2001-02-01), Pollock et al.
patent: 6221615 (2001-04-01), Chittenden et al.
patent: 6242569 (2001-06-01), Shu et al.
patent: 2002/0082206 (2002-06-01), Leach et al.
patent: 2005/0196754 (2005-09-01), Drmanac et al.
patent: 0 125 023 (1984-11-01), None
patent: 0 173 494 (1986-03-01), None
patent: 0 184 187 (1986-06-01), None
patent: 0 273 085 (1988-07-01), None
patent: 0 171 496 (1996-02-01), None
patent: 0 412 883 (1996-11-01), None
patent: 0 707 592 (1997-09-01), None
patent: 1074617 (2001-07-01), None
patent: 0 785 280 (2003-04-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 87/02671 (1987-05-01), None
patent: WO 88/06630 (1988-09-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 90/15070 (1990-12-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/10092 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
patent: WO 93/10151 (1993-05-01), None
patent: WO 94/02502 (1994-02-01), None
patent: WO 94/10300 (1994-05-01), None
patent: WO 94/10308 (1994-05-01), None
patent: WO 95/11995 (1995-05-01), None
patent: WO 96/33730 (1996-10-01), None
patent: WO 97/11714 (1997-04-01), None
patent: WO 99/31236 (1999-06-01), None
patent: WO 00/06728 (2000-02-01), None
patent: WO 00/28047 (2000-05-01), None
patent: WO 00/58473 (2000-10-01), None
patent: WO 01/12659 (2001-02-01), None
patent: WO 01/57190 (2001-08-01), None
patent: WO 01/57190 (2001-09-01), None
patent: W0 03/051917 (2003-06-01), None
patent: WO 03/051917 (2003-06-01), None
patent: WO 2004/055050 (2004-07-01), None
Burgess et al, Journal of Cell biology, vol. 111, p. 2129-2138, 1990.
Lin et al Biochemistry USA, vol. 14, p. 1559-1563, 1975.
Mesh Word, NCBI.
Sequence search result 2009.
Database Geneseq ′Online! Nov. 6, 2001 “Human Protein Seq ID No. 1928.” XP002309318.
Database Geneseq ′Online! Jun. 26, 2001 “Human Protein Sequence Seq ID No. 11440.” XP002309319.
Roussigne, M., et al. THAP1 is a Nuclear Proapoptotic Factor that Links Prostate-Apoptosis-Response-4 (Par-4) to PML Nuclear Bodies. Oncogene (2003) 22:2432-2442.
Roussigne, M., et al. The THAP Domain: a Novel Protein Motif with Similarity to the DNA-Binding Domain ofPElement Transposase. Trends in Biochemical Sciences (Feb. 2003) vol. 28, No. 2: 66-69.
Abravaya, et al. 1995. Detection of point mutations with a modified ligase chain reaction (Gap-LCR).Nucleic Acids Research, 23(4):675-682.
Adams, et al. 1998. The BcI-2 protein family: Arbiters of cell survival.Science, 281:1322-1326.
Alcalay, et al. 1998. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.Molecular and Cellular Biology, 18(2):1084-1093.
Alt, et al. 2002. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.Eur. J. Immunol., 32:2133-2144.
Altschul, et al. 1990. Basic local alignment search tool.J. Mol. Biol., 215:403-410.
Altschul, et al. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs.Nucleic Acids Research, 25(17):3389-3402.
Amann, et al. 1988. Tightly regulatedtacpromoter vectors useful for the expression of unfused and fused proteins inEscherichia coli. Gene, 69:301-315.
Amersham Biosciences. Scintillation Proximity Assay Manual. pp. 1-81.
Ammann, et al. 1997. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrongen deficiency.J. Clin. Invest., 99(7):1699-1703.
Arcone, et al. 1988. Identification of sequences responsible for acute-phase induction of human C-reactive protein.Nucleic Acids Research, 16(8):3195-3207.
Ashkenazi, et al. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.Proc. Natl. Acad. Sci. USA, 88:10535-10539.
Ausubel, et al. (Eds.). 1998. Current Protocols in Molecular Biology, vol. 1, Unit 6.3.1-6.3.6. John Wiley & Sons, Inc.
Baichwal, et al. 1986. “Vectors for gene transfer derived from animal DNA viruses: Transient and stable expression of transferred genes.” in Kucherlapati, R. (Ed.). Gene Transfer, pp. 117-147. New York: Plenum Press.
Baldari, et al. 1987. A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1β inSaccharomyces cerevisiae. The EMBO Journal, 6(1):229-234.
Barradas, et al. 1999. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.The EMBO Journal, 18(22):6362-6369.
Bartel, et al. 1993. Elimination of false positives that arise in using the two-hybrid system.BioTechniques, 14(6):920-924.
Bartlett, et al. 1996. Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters.Proc. Natl. Acad. Sci. USA, 93:8852-8857.
Beaucage, et al. 1981. Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis.Tetrahedron Letters, 22(20):1859-1862.
Beidler, et al. 1988. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.The Journal of Immunology, 141(11):4053-4060.
Benvenisty, et al. 1986. Direct introduction of genes into rats and expression of the genes.Proc. Natl. Acad. Sci. USA, 83:9551-9555.
Berra, et al. 1997. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade.Molecular and Cellular Biology, 17(8):4346-4354.
Besset, et al. 2000. Nuclear localization of PAPS synthetase 1: A sulfate activation pathway in the nucleus of eukaryotic cells.The FASEB Journal, 14:345-354.
Better, et al. 1988.Escherichia colisecretion of an active chimeric antibody fragment.Science, 240:1041-1043.
Blackwell, et al. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.Science, 250:1104-1110.
Bloch, et al. 1999. Structural and functional heterogeneity of nuclear bodies.Molecular and Cellular Biology, 19(6):4423-4430.
Boghaert, et al. 1997. Immun

Affiliated with

Also associated with

Rating

Chemokine-binding protein and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine-binding protein and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine-binding protein and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4214513